These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5580239)

  • 1. [Experience in the use of a new drug, amedine, in Parkinsonism].
    Vaĭnshtok AB; Oleĭnik LI
    Sov Med; 1971 Jan; 34(1):40-2. PubMed ID: 5580239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of parkinsonism].
    Oftedal SI
    Tidsskr Nor Laegeforen; 1969 Apr; 89(7):489-91. PubMed ID: 5794674
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary report on a new anti-Parkinson drug, UCB 1549.
    Strang RR
    Acta Neurol Psychiatr Belg; 1966 Sep; 66(9):771-6. PubMed ID: 4961572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathochemical bases for the treatment of parkinsonism].
    Petelin LS; Tret'iakova KA; Pigarev VA; Romenskaia LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1765-70. PubMed ID: 5143959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Parkinsonism with Tremarial (SJ-1977)].
    Kondo K; Takahashi Y; Yamamoto T; Matsumura K; Okuda Y
    No To Shinkei; 1967 Jul; 19(7):723-7. PubMed ID: 4384268
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H
    Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vascular parkinsonism and current methods for its drug treatment].
    Oleĭnik LI
    Feldsher Akush; 1984 Mar; 49(3):33-7. PubMed ID: 6562035
    [No Abstract]   [Full Text] [Related]  

  • 8. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of drug induced parkinsonism].
    Aquilonius S; Dolby J; Anggård E
    Lakartidningen; 1976 Feb; 73(7):511-4. PubMed ID: 1250040
    [No Abstract]   [Full Text] [Related]  

  • 10. Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up.
    De Smedt R; Rodrigus E; Debandt R; Brugmans J
    J Clin Pharmacol J New Drugs; 1970; 10(3):207-11. PubMed ID: 4910278
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of parkinsonism].
    Teräväinen H; Larsen TA
    Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
    Strang RR
    Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of disturbances of extrapyramidal system with methixene hydrochloride].
    Kuromaru S; Funasaka K; Shuta K
    No To Shinkei; 1969 Nov; 21(11):1301-9. PubMed ID: 5394922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of therapy of parkinsonism].
    Walton JN
    Recenti Prog Med; 1971 Sep; 51(3):274-88. PubMed ID: 5171957
    [No Abstract]   [Full Text] [Related]  

  • 15. New and OLD DRUGS FOR PARKINSONISM.
    Med Lett Drugs Ther; 1968 Sep; 10(18):69-72. PubMed ID: 5730145
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parkinsonism].
    Uono M
    Naika; 1970 Jun; 25(6):1301-4. PubMed ID: 5431294
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bulgarian antiparkinson preparations with a new mechanism of action].
    Ganev G; Karamalakov L; Tsekova M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1864-9. PubMed ID: 6000490
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy today: advances in treating parkinsonism.
    Rodman MJ
    RN; 1969 Nov; 32(11):59-69. PubMed ID: 5196573
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tremaril--a new antiparkinsonian drug].
    Naess K
    Tidsskr Nor Laegeforen; 1969 Aug; 89(16):1276-7. PubMed ID: 5375358
    [No Abstract]   [Full Text] [Related]  

  • 20. [New possibilities of drug treatment of Parkinson's syndrome through use of Akineton retard].
    Völler GW
    Med Welt; 1967 Feb; 6():345-9. PubMed ID: 5594247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.